Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 13,340 shares at $0.15 ($2K) on 2016-08-18, disclosed to the SEC on 2016-08-18.
Seasonal purchase ($2k) by CEO, 10% Owner — this insider has traded LXRP in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 11,340 | $1K | 83.1% |
| 2 | $0.15 | 2,000 | $300 | 16.9% |
| Total | $0.13 avg | 13,340 | $2K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |